3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, AC; Brandt, SL; Durham, TB; Eversley, JA; FitzGerald, GA; Hammond, CD; Liu, Y; Mohan, H; Prentice, KJ; Salvatore, SR; Schopfer, FJ; Serena Wang, X; Skarke, C; Sloop, KW; Wei, D; Wendell, SG; Wheeler, MB | 1 |
| Al Rijjal, D; Batchuluun, B; Belsham, DD; Bhattacharjee, A; Brandt, SL; Burdett, E; Cox, B; Cummins, CL; Kim, JH; Lai, M; Liu, Y; Magomedova, L; Mohan, H; Prentice, KJ; Wheeler, MB; Wong, F | 1 |
2 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Liver Steatosis
| Article | Year |
|---|---|
CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis.
Topics: Adult; Animals; Diet, High-Fat; Dietary Supplements; Dose-Response Relationship, Drug; Esters; Fatty Acids, Omega-3; Fatty Liver; Female; Fibroblast Growth Factors; Furans; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolome; Mice; Mice, Knockout; Mice, Obese; Propionates | 2018 |
3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis.
Topics: Animals; Blood Glucose; Body Weight; Diet, High-Fat; Fatty Liver; Fibroblast Growth Factors; Furans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Propionates | 2019 |